PAVmed Inc Stock Statistic Functions Beta
| PAVM Stock | USD 10.20 -0.20 -1.92% |
| Symbol |
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on PAVmed Inc correlated with the market. If Beta is less than 0 PAVmed generally moves in the opposite direction as compared to the market. If PAVmed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one PAVmed Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of PAVmed is generally in the same direction as the market. If Beta > 1 PAVmed moves generally in the same direction as, but more than the movement of the benchmark.
PAVmed Technical Analysis Modules
Most technical analysis of PAVmed help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for PAVmed from various momentum indicators to cycle indicators. When you analyze PAVmed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
PAVmed Inc. operates as a medical device company in the United States. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. Pavmed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 89 people. This overview emphasizes how PAVmed compares to peers on valuation quality and operating consistency. Current metrics include P/B of 1.13, profit margin of 106.72%. PAVmed has a market cap of 9.4 M, ROE of 17.44%.
Methodology
Unless otherwise specified, financial data for PAVmed Inc is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. PAVmed (USA Stocks:PAVM) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: This report references public filings and market reference sources and institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Certain datasets may update with delay depending on source availability. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
PAVmed Inc may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Ellen Johnson - Member of Macroaxis Editorial BoardBecome your own money manager
Tracking PAVmed inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Software Invested few shares | |
 | Hedge Favorites Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Investor Favorites Invested few shares | |
 | Social Domain Invested few shares | |
 | Advertising Invested few shares | |
 | Disruptive Technologies Invested few shares | |
 | Impulse Invested over 200 shares | |
 | Momentum Invested few shares | |
 | Baby Boomer Prospects Invested over 20 shares | |
 | Macroaxis Picks Invested few shares |
More Resources for PAVmed Stock Analysis
A structured review of PAVmed Inc often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Key reports that frame PAVmed Inc Stock are listed below:PAVmed has a market cap of 9.4 M, operating margin of -968.8%, ROE of 17.44%. Your Equity Center can help frame allocation decisions. The allocation includes a position in PAVmed Inc in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. Analysis related to PAVmed should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Earnings Share -12.00 | Revenue Per Share | Quarterly Revenue Growth -0.99 | Return On Assets | Return On Equity |
Market capitalization and book value offer complementary views of PAVmed Inc — the first driven by investor sentiment, the second by accounting standards. PAVmed's market capitalization is 9.4 M. A P/B ratio of 1.13 indicates the market values PAVmed above its accounting book value. Enterprise value stands at 43.09 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Value and price for PAVmed are related but not identical, and they can diverge across cycles. For PAVmed, key inputs include a P/B ratio of 1.13, a profit margin of 106.72%, ROE of 17.44%, and revenue of 3 M. Trading price represents the transaction level agreed by market participants.